We appreciate the comments by Drs Nair and Esquinas to our article,() to which we provide clarifications.
First, according to the institutional protocol, the use of high-flow nasal cannula (HFNC) therapy was contraindicated in patients with predominant mouth breathing, considering its ineffectiveness.()
Veiga VC, Silva LMCJ, Sady RR, Maia IS, Cavalcanti AB. Reply to: Epistaxis as a complication of high-flow nasal cannula therapy in adults. Rev Bras Ter Intensiva 2022;34(3):398.
Electronic Document Format (ABNT)
Veiga, Viviane Cordeiro; Silva, Lígia Maria Coscrato Junqueira; Sady, Érica Regina Ribeiro; Maia, Israel Silva; Cavalcanti, Alexandre Biasi. Reply to: Epistaxis as a complication of high-flow nasal cannula therapy in adults. Rev Bras Ter Intensiva, v. 34, n. 3, p. 398-398, Nov. 2022.
Electronic Document Format (APA)
Veiga, V. C., Silva, L. M. C. J., Sady, R. R., Maia, I. S., & Cavalcanti, A. B. (2022). Reply to: Epistaxis as a complication of high-flow nasal cannula therapy in adults. Rev Bras Ter Intensiva, 34(3), 398-398.
Electronic Document Format (ISO)
Veiga, Viviane Cordeiro and Silva, Lígia Maria Coscrato Junqueira and Sady, Érica Regina Ribeiro and Maia, Israel Silva and Cavalcanti, Alexandre Biasi. Reply to: Epistaxis as a complication of high-flow nasal cannula therapy in adults. Rev Bras Ter Intensiva [online]. 2022, vol. 34, n. 3, [cited 2024-07-03], pp.398-398. Available from: <https://criticalcarescience.org/article/reply-to-epistaxis-as-a-complication-of-high-flow-nasal-cannula-therapy-in-adults/>.
✕
Reply to: Epistaxis as a complication of high-flow nasal cannula therapy in adults |
TO THE EDITOR
We appreciate the comments by Drs Nair and Esquinas to our article,() to which we provide clarifications.
First, according to the institutional protocol, the use of high-flow nasal cannula (HFNC) therapy was contraindicated in patients with predominant mouth breathing, considering its ineffectiveness.()
Comments